Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 2
2015 1
2016 2
2018 1
2020 1
2021 3
2022 7
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Immunogenicity of ChAdOx1 nCoV-19 vaccine after a two-dose inactivated SARS-CoV-2 vaccination of dialysis patients and kidney transplant recipients.
Bruminhent J, Setthaudom C, Kitpermkiat R, Kiertiburanakul S, Malathum K, Assanatham M, Nongnuch A, Phuphuakrat A, Chaumdee P, Janphram C, Thotsiri S, Chuengsaman P, Boongird S. Bruminhent J, et al. Among authors: assanatham m. Sci Rep. 2022 Mar 4;12(1):3587. doi: 10.1038/s41598-022-07574-w. Sci Rep. 2022. PMID: 35246578 Free PMC article.
SARS-CoV-2-specific humoral and cell-mediated immune responses after immunization with inactivated COVID-19 vaccine in kidney transplant recipients (CVIM 1 study).
Bruminhent J, Setthaudom C, Chaumdee P, Boongird S, Kiertiburanakul S, Malathum K, Nongnuch A, Phuphuakrat A, Jirasiritham S, Janphram C, Thotsiri S, Upama S, Assanatham M; Ramathibodi Transplant Infectious Diseases (RTID) Study Group. Bruminhent J, et al. Among authors: assanatham m. Am J Transplant. 2022 Mar;22(3):813-822. doi: 10.1111/ajt.16867. Epub 2021 Dec 6. Am J Transplant. 2022. PMID: 34657386 Free PMC article.
An additional dose of viral vector COVID-19 vaccine and mRNA COVID-19 vaccine in kidney transplant recipients: A randomized controlled trial (CVIM 4 study).
Bruminhent J, Setthaudom C, Phornkittikorn P, Chaumdee P, Prasongtanakij S, Srisala S, Malathum K, Boongird S, Nongnuch A, Assanatham M, Nakgul L, Sanmeema N, Phuphuakrat A, Kiertiburanakul S; Ramathibodi Transplant Infectious Diseases (RTID) Study Group. Bruminhent J, et al. Among authors: assanatham m. Am J Transplant. 2022 Nov;22(11):2651-2660. doi: 10.1111/ajt.17151. Epub 2022 Jul 26. Am J Transplant. 2022. PMID: 35841235 Free PMC article. Clinical Trial.
Predicting treatment response and clinicopathological findings in lupus nephritis with urine epidermal growth factor, monocyte chemoattractant protein-1 or their ratios.
Ngamjanyaporn P, Worawichawong S, Pisitkun P, Khiewngam K, Kantachuvesiri S, Nongnuch A, Assanatham M, Sathirapongsasuti N, Kitiyakara C. Ngamjanyaporn P, et al. Among authors: assanatham m. PLoS One. 2022 Mar 10;17(3):e0263778. doi: 10.1371/journal.pone.0263778. eCollection 2022. PLoS One. 2022. PMID: 35271583 Free PMC article.
Anti-SARS-CoV-2 spike protein S1 receptor-binding domain antibody after vaccination with inactivated whole-virus SARS-CoV-2 in end-stage kidney disease patients: an initial report.
Boongird S, Chuengsaman P, Phanprasert S, Kitpermkiat R, Assanatham M, Nongnuch A, Kiertiburanakul S, Malathum K, Phuphuakrat A, Setthaudom C, Bruminhent J. Boongird S, et al. Among authors: assanatham m. Kidney Int. 2021 Nov;100(5):1136-1138. doi: 10.1016/j.kint.2021.08.007. Epub 2021 Aug 19. Kidney Int. 2021. PMID: 34419552 Free PMC article. No abstract available.
Durability of Humoral and Cellular Immunity after an Extended Primary Series with Heterologous Inactivated SARS-CoV-2 Prime-Boost and ChAdOx1 nCoV-19 in Dialysis Patients (ICON3).
Boongird S, Setthaudom C, Kitpermkiat R, Prasongtanakij S, Srisala S, Chuengsaman P, Nongnuch A, Assanatham M, Kiertiburanakul S, Malathum K, Phuphuakrat A, Bruminhent J. Boongird S, et al. Among authors: assanatham m. Vaccines (Basel). 2022 Jul 1;10(7):1064. doi: 10.3390/vaccines10071064. Vaccines (Basel). 2022. PMID: 35891228 Free PMC article.
Years of life lost and long-term outcomes due to glomerular disease in a Southeast Asian Cohort.
Janphram C, Worawichawong S, Assanatham M, Nongnuch A, Thotsiri S, Udomsubpayakul U, Wimolluck S, Poomjun N, Ingsathit A, Disthabanchong S, Sumethkul V, Aekplakorn W, Chalermsanyakorn P, Kitiyakara C. Janphram C, et al. Among authors: assanatham m. Sci Rep. 2023 Nov 5;13(1):19119. doi: 10.1038/s41598-023-46268-9. Sci Rep. 2023. PMID: 37926743 Free PMC article.
Short-Term Immunogenicity Profiles and Predictors for Suboptimal Immune Responses in Patients with End-Stage Kidney Disease Immunized with Inactivated SARS-CoV-2 Vaccine.
Boongird S, Chuengsaman P, Setthaudom C, Nongnuch A, Assanatham M, Phanprasert S, Kitpermkiat R, Kiertiburanakul S, Malathum K, Phuphuakrat A, Davenport A, Bruminhent J. Boongird S, et al. Among authors: assanatham m. Infect Dis Ther. 2022 Feb;11(1):351-365. doi: 10.1007/s40121-021-00574-9. Epub 2021 Dec 3. Infect Dis Ther. 2022. PMID: 34859359 Free PMC article.
16 results